Pharma
Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
Top Stories
STOCK TICKER: Blumenthal’s Wife Invests in Biotech Hedge Fund as He Chairs Panel Overseeing Drug Prices
By Donald Shaw STOCK TICKER Primary category in which blog post is published
Drug Lobby Revenues Skyrocket During Covid Pandemic
By Donald Shaw Lobbying Primary category in which blog post is published
Pharma Lobby Enlists Minority Groups to Fight Drug Pricing Reform
By Donald Shaw Health Primary category in which blog post is published
Corporate America Butters Up Likely Next Energy and Commerce Chair
By Donald Shaw 2022 Primary category in which blog post is published
Senators Against Generic Covid-19 Vaccines Have Gotten 2x Pharma Cash
A group of Republican senators sought to block U.S. support for an IP waiver for Covid-19 vaccines, a proposal that is strongly opposed by the pharmaceutical industry.
Pharma Front Group Hosted House Staffers at Luxury Resort Before BBB Vote
Days before the House voted on the Build Back Better Act, Center Forward hosted dozens of congressional staffers to discuss policy issues with lobbyists.
Health Insurance and Pharma Lobbyists Max Out to the Dem Party
The Senate braces for a showdown over expanding Medicare to include dental and vision benefits after healthcare industry lobbyists have bundled six-figure donations for Democrats’ campaign arms.
Top House Dem Buys Stock in Pharma Companies and Defense Contractors
House Budget Chair John Yarmuth is a frequent stock trader who recently purchased shares in companies that are lobbying against the Democrats' budget plan.
News Outlet Founded by Blue Dog Dem Operatives Promotes Big Pharma’s Lobbying Aims
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Biden Plans to Enact Trump Rule Allowing Drug Companies to Price Gouge on Life-Saving Treatments
The plan, initiated by the Trump administration in January, would gut a key government power for making sure taxpayer-funded pharmaceuticals are available to the public at reasonable prices.
Astroturf Campaign Attacks Discount Drug Program for the Poor
An anti-government waste group is helping its Big Pharma funder oppose a discount drug program that doesn’t cost the government a penny.
Blue Dog-Affiliated Group Runs Ads for Big Pharma
Center Forward, a "dark money" group with major funding from Big Pharma, is running a Facebook ad campaign touting the pharmaceutical industry as its super PAC spends millions to re-elect Blue Dog Democrats.
